Global 30-Day Morbidity and Mortality of Primary Bariatric Surgery Combined with Another Procedure: The BLEND Study
- PMID: 38869833
- DOI: 10.1007/s11695-024-07296-0
Global 30-Day Morbidity and Mortality of Primary Bariatric Surgery Combined with Another Procedure: The BLEND Study
Abstract
Background: No robust data are available on the safety of primary bariatric and metabolic surgery (BMS) alone compared to primary BMS combined with other procedures.
Objectives: The objective of this study is to collect a 30-day mortality and morbidity of primary BMS combined with cholecystectomy, ventral hernia repair, or hiatal hernia repair.
Setting: This is as an international, multicenter, prospective, and observational audit of patients undergoing primary BMS combined with one or more additional procedures.
Methods: The audit took place from January 1 to June 30, 2022. A descriptive analysis was conducted. A propensity score matching analysis compared the BLEND study patients with those from the GENEVA cohort to obtain objective evaluation between combined procedures and primary BMS alone.
Results: A total of 75 centers submitted data on 1036 patients. Sleeve gastrectomy was the most commonly primary BMS (N = 653, 63%), and hiatal hernia repair was the most commonly concomitant procedure (N = 447, 43.1%). RYGB accounted for the highest percentage (20.6%) of a 30-day morbidity, followed by SG (10.5%). More than one combined procedures had the highest morbidities among all combinations (17.1%). Out of overall 134 complications, 129 (96.2%) were Clavien-Dindo I-III, and 4 were CD V. Patients who underwent a primary bariatric surgery combined with another procedure had a pronounced increase in a 30-day complication rate compared with patients who underwent only BMS (12.7% vs. 7.1%).
Conclusion: Combining BMS with another procedure increases the risk of complications, but most are minor and require no further treatment. Combined procedures with primary BMS is a viable option to consider in selected patients following multi-disciplinary discussion.
Keywords: Combined procedures; Concomitant cholecystectomy; Concomitant hiatal hernia repair; Concomitant ventral hernia repair; Primary bariatric and metabolic surgery.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Concurrent ventral hernia repair in patients undergoing laparoscopic bariatric surgery: a case-matched study using the National Surgical Quality Improvement Program Database.Surg Obes Relat Dis. 2017 Jun;13(6):997-1002. doi: 10.1016/j.soard.2017.01.007. Epub 2017 Jan 6. Surg Obes Relat Dis. 2017. PMID: 28274707
-
Concurrent bariatric surgery and paraesophageal hernia repair: an analysis of the Metabolic and Bariatric Surgery Association Quality Improvement Program (MBSAQIP) database.Surg Obes Relat Dis. 2019 Oct;15(10):1746-1754. doi: 10.1016/j.soard.2019.08.025. Epub 2019 Sep 5. Surg Obes Relat Dis. 2019. PMID: 31588008
-
Concurrent Laparoscopic Ventral Hernia Repair with Bariatric Surgery: a Propensity-Matched Analysis.J Gastrointest Surg. 2020 Jan;24(1):58-66. doi: 10.1007/s11605-019-04291-0. Epub 2019 Jun 26. J Gastrointest Surg. 2020. PMID: 31243713
-
Management of Paraesophageal Hernia in the Morbidly Obese Patient.Thorac Surg Clin. 2019 Nov;29(4):379-386. doi: 10.1016/j.thorsurg.2019.07.003. Epub 2019 Sep 26. Thorac Surg Clin. 2019. PMID: 31564394 Review.
-
Concomitant ventral hernia repair and bariatric surgery: a retrospective analysis from a UK-based bariatric center.Surg Endosc. 2019 Mar;33(3):705-710. doi: 10.1007/s00464-018-6492-6. Epub 2018 Oct 19. Surg Endosc. 2019. PMID: 30341658 Review.
Cited by
-
"Global 30-Day Morbidity and Mortality of Primary Bariatric Surgery Combined with Another Procedure: The BLEND Study".Obes Surg. 2025 Feb;35(2):668. doi: 10.1007/s11695-025-07678-y. Epub 2025 Jan 10. Obes Surg. 2025. PMID: 39789361 No abstract available.
-
Outcomes of Concomitant Laparoscopic Sleeve Gastrectomy and Hiatal Hernia Repair on Gastroesophageal Reflux Disease in Patients with Severe Obesity: A Propensity Score-Matched Analysis.Obes Surg. 2025 May;35(5):1685-1692. doi: 10.1007/s11695-025-07815-7. Epub 2025 Apr 9. Obes Surg. 2025. PMID: 40205116
References
-
- Kloock S, Ziegler CG, Dischinger U. Obesity and its comorbidities, current treatment options and future perspectives: challenging bariatric surgery? Pharmacol Ther. 2023;251:108549. https://doi.org/10.1016/j.pharmthera.2023.108549 . - DOI - PubMed
-
- Eisenberg D, Shikora SA, Aarts E, et al. 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): indications for metabolic and bariatric surgery. Surg Obes Relat Dis. 2022;18(12):1345–56. https://doi.org/10.1016/j.soard.2022.08.013 . - DOI - PubMed
-
- Dorman RB, Zhong W, Abraham AA, et al. Does concomitant cholecystectomy at time of Roux-en-Y gastric bypass impact adverse operative outcomes? OBES SURG. 2013;23(11):1718–26. https://doi.org/10.1007/s11695-013-1001-4 . - DOI - PubMed
-
- Yardimci S, Coskun M, Demircioglu S, et al. Is concomitant cholecystectomy necessary for asymptomatic cholelithiasis during laparoscopic sleeve gastrectomy? OBES SURG. 2018;28(2):469–73. https://doi.org/10.1007/s11695-017-2867-3 . - DOI - PubMed
-
- Allatif REA, Mannaerts GHH, Al Afari HST, et al. Concomitant cholecystectomy for asymptomatic gallstones in bariatric surgery—safety profile and feasibility in a large tertiary referral bariatric center. OBES SURG. 2022;32(2):295–301. https://doi.org/10.1007/s11695-021-05798-9 . - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical